Secondary Acute Myeloid Leukemia (AML)
2 clinical trials · Condition
◉ Watch Secondary Acute Myeloid Leukemia (AML)
| Record | Firm | Date |
|---|---|---|
| A Dose Confirmation Study of Oral Clofarabine for Adult Patients Previously Treated for Myelodysplastic Syndromes (MDS) (NCT00531232) | Genzyme, a Sanofi Company | 2007-05-07 |
| Treatment of Adults Aged Up to 60 Years With De Novo Acute Myeloblastic Leukaemia,Secondary AML, or RAEB-T (NCT00209833) | Hannover Medical School | 1999-01-01 |
Track Secondary Acute Myeloid Leukemia (AML) automatically
Every clearance here is in the API, with alerts when new ones post.